Navigation Links
American Oriental Bioengineering to Report Second Quarter 2010 Financial Results on August 9, 2010
Date:8/4/2010

NEW YORK, Aug. 4 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that it plans to release second quarter 2010 financial results on Monday, August 9, 2010, before the market opens.

The Company will hold a conference call at 8:00 am ET on Monday, August 9, to discuss its results. Listeners may access the call by dialing 1-800-573-4842 or 1-617-224-4327 for international callers, access code: 10613898. A webcast will also be available through AOB's website at http://www.bioaobo.com .

A replay of the call will be available through August 16, 2010. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 35043398.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-K for the year ended December 31, 2010, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
2. Home Medical Equipment Providers Recognize Americans with Disabilities Act 20th Anniversary, Vow to Fight for Greater Access to Care
3. Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo
4. Wound Management Technologies, Inc. Expands Distribution Channel into Five Central American Countries
5. United American Healthcare Corporation Announces Change to Meeting Date for Annual Meeting of Shareholders
6. American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy
7. eDataAudit Receives Approval from the American Board of Radiology
8. Varian Medical Systems to Showcase Fast, Precise Brachytherapy Planning System at Annual Meeting of American Association of Physicists in Medicine
9. Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
10. Profil Institute Teams Up With American Diabetes Association to Step Out Against Diabetes
11. Hot Times in the City: As Summer Temperatures Soar, Pulse of Passion Survey Reveals What Makes Americans Sizzle in Relationships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... FRANCISCO , March 27, 2017  Twist Bioscience, ... DNA synthesis, today announced that it raised an additional ... total of $166 million. "It is ... we expand our reach and continue to deliver industry-leading ... multiple market segments," commented Emily M. Leproust, Ph.D., CEO ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/27/2017)... 2017 Invivotek, LLC, a Genesis Biotechnology Group ... pharmacology contract research organization (CRO), announced the completion ... expanded preclinical research facility in Hamilton, New ... renewable energy source to reduce costs and lessen the ... Genesis Solar Farm follows Invivotek,s recent expansion from a ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination ... are complicated and require expert user knowledge. In a live webinar on April ... the simplified, yet highly accurate, determination of sodium. , It has long been ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center ... Monday, April 3rd to commemorate the two-year anniversary of the facility. The event ... celebrate two great years while also familiarizing themselves with the facility. , In ...
(Date:3/27/2017)... , ... March 27, 2017 , ... Harris Communications, Inc., ... hearing, is bringing its latest products to the Deaf Seniors of America Conference, April ... the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications and to ...
(Date:3/25/2017)... Wisconsin (PRWEB) , ... March 25, 2017 , ... Norland at Swissray is ... composition analyzers for large subjects. The ELITE DXA has an active scan window, which ... wide or long to fit in the scan area could not undergo an accurate total ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... will spark a conversation on the current obstacles facing infection prevention and offer ... preventable deaths caused by these infections. , The print component of “Fighting ...
Breaking Medicine News(10 mins):